Numerous studies demonstrated that the LDOC1 gene inhibits ligand-induced NF-κB activity in oral squamous cell carcinoma (Lee et al., 2013), papillary thyroid carcinoma (Zhao et al., 2015), and pancreatic cancer cells (Nagasaki et al., 2003). The gene discussed is LDOC1; the disease is pancreatic neoplasm.